Orchestra BioMed Correlations
OBIO Stock | 5.62 0.11 2.00% |
The current 90-days correlation between Orchestra BioMed Holdings and Hooker Furniture is 0.19 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Orchestra BioMed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Orchestra BioMed Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Orchestra BioMed Correlation With Market
Average diversification
The correlation between Orchestra BioMed Holdings and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Orchestra BioMed Holdings and DJI in the same portfolio, assuming nothing else is changed.
Orchestra |
Moving together with Orchestra Stock
Moving against Orchestra Stock
0.59 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.46 | LLY | Eli Lilly | PairCorr |
0.43 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
0.61 | NUVL | Nuvalent | PairCorr |
0.56 | AKAN | Akanda Corp | PairCorr |
0.47 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.42 | MRVI | Maravai Lifesciences | PairCorr |
0.38 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
0.61 | TELO | Telomir Pharmaceuticals, | PairCorr |
0.55 | ANRO | Alto Neuroscience, | PairCorr |
0.51 | TTOO | T2 Biosystms | PairCorr |
0.49 | BCDA | Biocardia | PairCorr |
0.49 | BNTX | BioNTech SE | PairCorr |
0.45 | ARDX | Ardelyx | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Orchestra Stock performing well and Orchestra BioMed Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Orchestra BioMed's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CNLFF | 0.05 | 0.02 | 0.00 | (1.20) | 0.00 | 0.00 | 1.03 | |||
GZITF | 0.84 | 0.47 | 0.00 | (1.05) | 0.00 | 0.00 | 26.67 | |||
VRRM | 1.22 | (0.23) | 0.00 | (0.26) | 0.00 | 2.49 | 14.00 | |||
MESA | 2.88 | (0.04) | 0.00 | (0.28) | 0.00 | 6.19 | 28.65 | |||
APOG | 1.76 | 0.14 | 0.16 | 0.18 | 1.45 | 3.41 | 28.75 | |||
HOFT | 2.53 | (0.06) | 0.02 | 0.08 | 2.98 | 5.56 | 14.21 | |||
AFYA | 1.47 | 0.00 | (0.05) | 0.06 | 1.97 | 2.62 | 9.86 |
Orchestra BioMed Corporate Management
Yuval DSc | GM Therapies | Profile | |
George Papandreou | Senior Therapies | Profile | |
Avraham MD | Senior Innovation | Profile | |
Andrew MBA | Chief Officer | Profile | |
HansPeter MD | Chief Officer | Profile |